Clinical Trial Update: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of liraglutide for type 2 diabetes is in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: UNKNOWN